Turkish Journal of Biology
Volume 42

Number 5

Article 5

1-1-2018

In vitro anticancer effect of tricyclic antidepressant nortriptyline
on multiple myeloma
AYŞENUR BİBER
İPEK ZEYNEP DURUSU
CAN ÖZEN

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
BİBER, AYŞENUR; DURUSU, İPEK ZEYNEP; and ÖZEN, CAN (2018) "In vitro anticancer effect of tricyclic
antidepressant nortriptyline on multiple myeloma," Turkish Journal of Biology: Vol. 42: No. 5, Article 5.
https://doi.org/10.3906/biy-1802-11
Available at: https://journals.tubitak.gov.tr/biology/vol42/iss5/5

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Biology

Turk J Biol
(2018) 42: 414-421
© TÜBİTAK
doi:10.3906/biy-1802-11

http://journals.tubitak.gov.tr/biology/

Research Article

In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma
Ayşenur BİBER, İpek Z. DURUSU, Can ÖZEN*
Biotechnology Graduate Program, Central Laboratory, Center of Excellence for Biomaterials and Tissue Engineering, Middle East
Technical University, Ankara, Turkey
Received: 02.02.2018

Accepted/Published Online: 02.07.2018

Final Version: 25.10.2018

Abstract: Drug repurposing has been proved to be an effective strategy to meet the urgent need for novel anticancer agents for multiple
myeloma (MM) treatment. In this work, we aimed to investigate the anticancer effect and mechanism of tricyclic antidepressant
nortriptyline (NTP) on the U266 MM cell line. The in vitro inhibitory effect of NTP at various doses and time points was studied.
The combination potential of cisplatin-NTP was also investigated. Cell cycle analysis and three flow cytometric apoptosis assays were
performed. NTP showed dose- and time-dependent inhibitory effects on the U266 MM cell line. NTP had greater inhibitory effect
than cisplatin (IC50 26 µM vs. 40 µM). The cisplatin-NTP combination is antagonistic. In addition to G2/M phase cell cycle arrest,
NTP induced apoptosis as indicated by mitochondrial membrane potential and caspase-3 and annexin V assays. NTP has inhibitory
and apoptotic effects on U266 MM cells. The cisplatin-NTP combination indicated strong antagonism, which may have significant
clinical relevance since antidepressants are commonly employed in adjuvant therapy for cancer patients. Based on these findings, the
therapeutic potential of NTP for MM treatment should be investigated with in-depth mechanistic studies and in vivo experiments.
Key words: Tricyclic antidepressant, combination chemotherapy, cancer, apoptosis, multiple myeloma

1. Introduction
Multiple myeloma (MM) is a cancer of plasma cells. It
is a complex hematological malignancy in which the
interaction of neoplastic B cells with the bone marrow
microenvironment plays a critical role in the progression of
the disease. MM is the second most common blood cancer
(10% of all blood cancers) and accounts for approximately
1% of all new cancer cases (Rajkumar, 2014). Effective
combination chemotherapy including proteasome
inhibitors (bortezomib) and immunomodulatory agents
(lenalidomide) has significantly increased the survival
rate of patients (Mimura et al., 2015; Röllig et al., 2015).
However, a high rate of relapse, especially due to multidrug
resistance, requires the addition of new drugs to existing
chemotherapy strategies.
Tricyclic antidepressants (TCAs) belong to a broad class
of psychoactive drugs. Interestingly, they also show potent
in vitro and in vivo anticancer effects on a large variety of
tumor cells such as colon, osteosarcoma, prostate, glioma,
skin squamous carcinoma, and MM (Frick and Rapanelli,
2013).
Nortriptyline (NTP), a classic TCA, also displays
antineoplastic effects on osteosarcoma, prostate,
melanoma, and bladder cancer (Hsu et al., 2004; Pan et al.,

2010; Mao et al., 2011; Yuan et al., 2015). Pan et al. showed
that NTP inhibits proliferation and induces apoptosis in
human prostate cancer (PC3) cells (Pan et al., 2010). More
recently, Yuan et al. investigated the therapeutic potential
of NTP on bladder cancer and observed cell cycle arrest,
intrinsic and extrinsic apoptosis, increase in reactive
oxygen species production, and suppression of tumor
growth in mice (Yuan et al., 2015).
Based on previous findings on its antitumor potential
and results from our screening studies, we investigated
NTP’s potency and the mechanism of its anticancer effect
on the U266 MM cell line.
2. Materials and methods
2.1. Chemicals
Clomipramine, imipramine, amitriptyline, maprotiline,
and mianserin were purchased from Alfa Aesar
(Lancashire, UK). Opipramol, protriptyline, nortriptyline,
desipramine, and cisplatin were obtained from SigmaAldrich (Taufkirchen, Germany).
2.2. Cell vulture
Human MM cell line U266 was kindly provided by
Professor Yusuf Baran (İzmir Institute of Technology, İzmir,

* Correspondence: canozen@metu.edu.tr

414

This work is licensed under a Creative Commons Attribution 4.0 International License.

BİBER et al. / Turk J Biol
Turkey) and maintained in RPMI 1640 growth medium
supplemented with 10% fetal bovine serum, 1% penicillin/
streptomycin, and 2.5 µg/mL Plasmocin prophylactic at 37
°C in a 5% CO2 incubator. Drug treatment was performed
at 105 cells/mL density.
2.3. Cell viability assays
Drug cytotoxicity screening, potency (IC50) determination,
and time-response and combination assays were completed
using the Promega (Madison, WI, USA) CellTiterBlue cell viability assay. For each sample, five technical
replicates were prepared. Measurements were taken with
a Molecular Devices (Sunnyvale, CA, USA) SpectraMax
Paradigm fluorescence plate reader at 555 nm excitation
and 595 nm emission settings. IC50 values were calculated
with GraphPad Prism v5.0 (GraphPad Inc., La Jolla, CA,
USA). Combination index (CI) values were calculated
using CompuSyn software (ComboSyn Inc., Paramus, NJ,
USA) (Chou, 2006).
2.4. Flow cytometry
Cell cycle analysis and apoptosis assays were carried out
with a BD Biosciences (San Diego, CA, USA) Accuri C6
flow cytometer.
2.5. Cell cycle analysis
Cells were treated with 15 µM NTP for 24 h and harvested.
After a cold PBS wash, samples were fixed with 70% ethanol
and kept for 2 h on ice. Following centrifugation and PBS
washing, cells were stained with propidium iodide (25 µg/
mL) in PBS (30 min, 37 °C). The staining solution also
contained 3 mg/mL RNAse. Samples were then analyzed
with a flow cytometer.
2.6. Apoptosis assays
Cells were treated with 30 µM NTP and analyzed at time
points of 12, 24, and 48 h with flow cytometry. Samples
were prepared as described in the manufacturer`s
procedures. To study the effect of NTP treatment on
mitochondrial membrane polarization, the BD Biosciences
MitoScreen Flow Cytometry Mitochondrial Membrane
Potential Detection Kit was used. Active caspase-3 and
phosphatidylserine detection was achieved with the PE
Active Caspase-3 Apoptosis Kit and Annexin V Apoptosis
Detection Kit I from the same manufacturer. Fluorescence
micrographs were obtained using a Zeiss (Oberkochen,
Germany) LSM 510 confocal laser scanning microscope
equipped with PlanNeofluar 40x/1.3 Oil DIC objective.
2.7. Statistical analysis
For cytotoxicity screening and time-response and
annexin-V assays, statistical significance of results was
analyzed using GraphPad Prism with one-way ANOVA
and the Tukey posttest module. Other experiments
were evaluated using unpaired t-tests with two tails.
Significances of differences are marked in figures with
asterisks. Statistical analyses were conducted on data from
three independent experiments.

3. Results
3.1. Potency screening of selected antidepressants
We screened seven tricyclic (imipramine, clomipramine,
amitriptyline, opipramol, desipramine, protriptyline,
nortriptyline) and two tetracyclic (maprotiline, mianserin)
antidepressants for their effects on the viability of the U266
MM cell line. Each drug was applied at 100 µM for 24 h.
Except mianserin, all tested TCAs and maprotiline showed
significant inhibitory effects on cell growth (Figure 1).
Imipramine and opipramol exhibited relatively weaker
inhibition compared to others. The tricyclic side chain
seems to have a critical role since its drastic modification
(opipramol) or removal (mianserin) diminished the effect
on cell viability. Among the positive hits, we selected NTP
for further in vitro characterization. To our knowledge,
this is the first report investigating the mechanism of
NTP’s effect on MM.
3.2. Nortriptyline shows dose- and time-dependent
toxicity on U266 cells
Dose and time dependences of NTP’s effect on U266 cells
were examined in the range of 1 µM to 120 µM and at time
points of 12, 24, and 48 h. We also calculated the IC50 of
NTP at 24 h (Figure 2A). The potency of cisplatin (cis), an
anticancer drug currently in clinical use for MM treatment,
was also determined for comparison. The IC50 values of
NTP and cis were determined as 26.1 ± 1.0 and 39.8 ±
9.9. The solubility problem of cis made it quite difficult
to reduce the variation among the biological replicates,
resulting in a higher error in calculation. Keeping this in
mind, NTP seems to be a more potent agent against MM.
As expected, longer NTP treatment corresponds to higher
inhibitory effects on cell viability (Figure 2B).
3.3. Nortriptyline-cisplatin combination is antagonistic
Cancer treatment efficiency significantly increases when
drugs are used in combination. Based on the promising
anticancer potential of NTP shown in the previous
section, we decided to test the cis-NTP combination on
MM cell viability. The molar ratio of the mixed drugs
is a critical factor determining the type (synergistic,
antagonist, or additive) and strength of the combination
effect (Tsakalozou et al., 2012). In this study, we used a
simple approach with only four combinations as listed in
the Table. Results were analyzed with CompuSyn software.
Interestingly, all four cis-NTP combinations resulted in
strong antagonism as indicated by the corresponding CI
values.
3.4. Nortriptyline arrests U266 cell cycle at G2/M phase
The inhibitory effect of NTP on U266 cells may arise
from antiproliferative and/or cytotoxic mechanisms.
We first investigated antiproliferative effect by analyzing
the progression of cell cycle with propidium iodide (PI)
staining and flow cytometry after NTP treatment (15 µM,
24 h). Distribution of untreated and NTP-treated cells at G1
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Figure 1. Effect of selected antidepressants (100 µM, 24 h) on viability of U266 cells. Drug structures are shown above
the corresponding bars. Asterisks denote statistical significance at P < 0.0001 (n = 3).
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Figure 2. Dose and time response of NTP’s inhibitory effect on U266 cell viability. A) Dose
response and potency (IC50) determination (n = 3). Concentration range was 1.0 to 120
µM. B) Time response (12, 24, and 48 h) of nortriptyline treatment at 5, 15, and 30 µM.
Asterisks denote statistical significance at P < 0.001 (n = 3).

(44.9% vs. 38.7%), S (25.5% vs. 20.5%), and G2/M (29.1%
vs. 40.2%) phases of cell cycle are provided in Figure 3.
According to these results, there is a statistically significant
difference in the G2/M populations of untreated and NTPtreated cells, indicating a drug-induced cell cycle arrest.
Based on previous TCA studies, we expected NTP to
induce apoptosis. In the following part, three common
apoptotic biomarkers were probed to test this strong
possibility.
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3.5. Nortriptyline causes mitochondrial membrane
depolarization
Mitochondria play a critical role in programmed cell death
and depolarization of the mitochondrial membrane was
shown to be one of the early events of apoptosis in some
earlier cases (Salvioli et al., 1997). To investigate the effect
of NTP (30 µM) on mitochondrial membrane potential,
we used JC-1 staining and analyzed the treated cells at 12,
24, and 48 h with flow cytometry. Red-to-green shift of the
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Figure 3. Effect of nortriptyline treatment (15 µM, 24 h) on U266 cell cycle. A) Representative flow cytometry fluorescence intensity
histograms of cells stained with propidium iodide. Intensity ranges for corresponding cell-cycle phases (G0/G1, S, and G2/M) are
labeled. B) Bar plots of normalized count values of each phase for untreated and nortriptyline-treated cells (n = 3). Error bars (1%–3%)
indicate standard error of mean. Asterisks denote statistical significance at P < 0.05.
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Figure 4. Effect of nortriptyline (30 µM) on mitochondrial membrane potential as a function of treatment time (12, 24, and 48 h). A)
Representative flow cytometry fluorescence intensity dot plots of cells stained with JC-1. Gated fluorescence intensity values for polarized
and depolarized states are labeled. B) Bar plots of normalized mitochondrial membrane polarization state values for untreated and
nortriptyline-treated cells (n = 3). Error bars (1%–3%) indicate standard error of mean. Asterisks * and ** denote statistical significance
at P < 0.05 and P < 0.01, respectively
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Figure 5. Caspase-3 activity of nortriptyline-treated (30 µM) U266 cells at 12, 24, and 48 h. A) Representative flow cytometry fluorescence
intensity histograms of cells stained with antiactive caspase-3 PE. Intensity threshold for caspase-3 activity is indicated in the upperleft panel. B) Bar plots of corresponding histograms (n = 3). Error bars (4%–5 %) indicate standard error of mean. Asterisks denote
statistical significance at P < 0.05.
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Figure 6. Flow cytometry analysis (12, 24, and 48 h) of annexin V-PE/7-AAD-stained U266 cells treated with 30 µM nortriptyline.
A) Representative dot plots of annexin V-PE vs. 7-AAD signals gated as live, early apoptotic, and late apoptotic quadrants. B) Cell
population bar graphs of corresponding dot plot quadrants (n = 3). Fluorescence micrograph of a late apoptotic cell is also shown for
24 h NTP treatment. Asterisks *, **, and *** denote statistical significance between control and treatment populations at P < 0.05, P <
0.01, and P < 0.001, respectively
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Table. Inhibitory effect of NTP, cis, and cis-NTP combination at 24 h (n = 2). Combination
index (CI) < 1 (synergy), CI = 1 (additivity), CI > 1 (antagonism).
NTP (µM)

Cis (µM)

Combination cytotoxicity (%)

Combination index (CI)

6

6

8.1 ± 0.3

1.8 ± 0.2

15

15

26.9 ± 1.6

2.0 ± 0.0

30

30

65.5 ± 1.7

1.7 ± 0.3

45

45

84.7 ± 3.0

1.5 ± 0.2

JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazol
carbocyanine iodide) fluorescence in the flow cytometry
histograms (Figure 4) was used as an indicator of the
mitochondrial health.
The majority of the control and NTP-treated cell
populations had healthy mitochondria (polarized
membrane) at 12 h. However, the depolarization signal
of the drug-treated cells started to increase at 24 h (3%
control vs. 15% NTP) and became almost tenfold higher at
48 h (4% control vs. 39% NTP).
3.6. Nortriptyline increases caspase-3 activity
Caspase-3 is a key protease activated in both intrinsic and
extrinsic apoptotic pathways at an early stage. We used an
immunofluorescence-based caspase-3 assay to specifically
detect the active form of the protease as a second apoptotic
biomarker. NTP treatment had no significant effect on
active caspase-3 level at 12 h (Figure 5). However, druginduced significant rises were observed at 24 h (5% control
vs. 28% NTP) and 48 h (6% control vs. 35% NTP).
3.7. Annexin-V assay also indicates nortriptylineinduced apoptosis
As the last apoptotic indicator, we employed annexin-V,
which is based on the loss of cell membrane phospholipid
asymmetry. As labeled in the dot plot (Figure 6), healthy
cells are PE-annexin V-negative and 7-AAD-negative,
early apoptotic cells are PE-annexin V-positive and
7-AAD-negative, and late apoptotic/dead cells are PEannexin V-positive and 7-AAD-positive. Starting at 12 h,
NTP treatment caused a significant decrease in the healthy
cell population (76% control vs. 24% treatment). As the
treatment time extended to 24 and 48 h, increases in the
percentage of early and late apoptotic cells (~4-fold and
6-fold in 24 h, ~7-fold and ~8-fold in 48 h, respectively) also
became significant. Fluorescence microscopy observations
(Figure 6B, boxed micrograph) also confirmed flow
cytometry findings. Collectively, all three assay results
show that NTP induces apoptosis in U266 cells.

4. Discussion
Results on the inhibitory effect and mechanism of NTP
reported in this work agree with previous studies that
strongly supported the anticancer effect of antidepressants
(Frick and Rapanelli, 2013).
NTP has dose- and time-dependent inhibitory effects
on U266 MM cells. Similar results were obtained by
others on osteosarcoma, prostate, melanoma, and bladder
cancer cells (Hsu et al., 2004; Pan et al., 2010; Mao et
al., 2011; Yuan et al., 2015). IC50 values of NTP on MM
cells (26 µM) and bladder cancer cells (40 µM, Yuan et
al., 2015) are similar. Within 24 h, NTP arrested the cell
cycle, caused mitochondrial membrane depolarization,
increased active caspase-3 levels, and induced loss of cell
membrane asymmetry. These observations confirm both
antiproliferative and apoptotic effects of the drug on U266
cells.
Yuan et al. found that NTP has less than 20% inhibitory
effect on peripheral blood mononuclear cells at a high
concentration (100 µM). In addition, Mao et al. reported
that amitriptyline, the methylated form of NTP (Figure 1),
was not cytotoxic to normal blood cells (Mao et al., 2011).
These findings and the fact that NTP is an approved drug
support the safety of its potential use in cancer therapy.
Comparison of in vitro potency and in vivo serum
concentration is another important point that needs
addressing. Approximately 10 µM NTP was detected in the
serum after daily administration at typical doses up to 75
mg (Yeragani et al., 2012). This concentration is about onethird of the calculated IC50 value. Therefore, at this point,
it is quite difficult to judge the clinical potential of NTP
for MM treatment without additional in vivo experiments.
NTP in combination with cis was shown to be
antagonistic within the tested dose regime. This is a
clinically relevant finding since adjuvant therapy with
antidepressants is commonly used for cancer patients
(Kabolizadeh et al., 2012). In recent years, some other
antidepressants (paroxetine, fluoxetine, and bupropion)
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were also shown to have a negative effect on a commonly
used cancer drug, tamoxifen, in breast cancer patients
by inhibiting the metabolic conversion of the drug into
its active form (Desmarais and Looper, 2009; Kelly et al.,
2010). Based on our results and the tamoxifen example,
we suggest that NTP may also have a negative impact on
the clinical effectiveness of cis-containing chemotherapy
regimens. On the other hand, there are also examples
revealing the synergistic effect of TCAs in combination
with other drugs. Amitriptyline combinations with
dexamethasone and bortezomib were shown to have
synergy on myeloma and MM cells (Mao et al., 2011;
Zhang et al., 2013). Similarly, combining clomipramine
with LiCl or imatinib also resulted in a synergism on
neuroblastoma and glioma cells (Bilir et al., 2008, 2010;
Zhang et al., 2013).
There are at least two reported cases in which cis
combinations with gefitinib and fingolimod were
antagonistic (Tsai et al., 2011; Zhang et al., 2013). To our
knowledge, the cis-NTP combination was not previously
investigated; however, we found a study by Kabolizadeh
et al., which involves desipramine, a structural analog of
NTP (Figure 1) (Kabolizadeh et al., 2012). In this work,
desipramine (5 to 50 µM) highly enhanced the cytotoxicity
of cis (1 to 15 µM) on colorectal carcinoma cell lines with
CI values reported in from 0.174 to 0.922.
The antagonistic effect of the cis-NTP combination
may have more than one explanation. Direct drug–
drug interaction may be one of these, although such an
interaction was not evident in the cis-desipramine case
as shown by nuclear magnetic resonance experiments
(Kabolizadeh et al., 2012). NTP might have caused an
increase in the DNA repair mechanism, which would
diminish the susceptibility of cis-induced DNA damage.
NTP may also reduce the cellular accumulation of cis,
as in the case of cis-Raf kinase inhibitor BAY 43-9006
combination (Heim et al., 2005). In this scenario, most
likely the NTP target would be organic cation transport
machinery, which was previously proposed for cellular cis
uptake (Koepsell et al., 2007; Hall et al., 2008). Another
possibility is the activation of conflicting signaling
pathways by cis and NTP. A related TCA, imipramine, has
been previously shown to induce autophagy in glioma cells
(Jeon et al., 2011). Induction of autophagic machinery by
NTP might have interfered with the apoptotic pathway of
cis-induced cell death.
NTP arrested U266 cells at the G2/M phase of the
cell cycle. Yuan et al. also reported cell cycle arrest at G0/
G1 and G2/M phases in NTP-treated human and mouse
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bladder cancer cells (Yuan et al., 2015). Amitriptyline
(20 µM, 24 h) arrests KMS11 and LP1 MM cells at G0/
G1 by downregulating cyclin D expression and increasing
expression of cyclin-dependent kinase inhibitors p27 and
p21 (Mao et al., 2011). Overexpression of p21 and p27
and cell cycle arrest was also reported in skin squamous
carcinoma Ca3/7 cells treated with desipramine (Kinjo et
al., 2009). Finally, fluoxetine-induced G0/G1 arrest in lung
and colon tumor cells was shown to involve cyclin A, cyclin
D1, p21, and p53 (Stepulak et al., 2008). As summarized
above, all TCAs seem to have cell cycle arrest effects on
cancer cells. Is there a significance of the phase in which
the cells are arrested? Ruetz et al. and DiPaola both reached
the conclusion that G2/M arrest is less well tolerated by
the cells, leading to increased apoptotic outcome (DiPaola,
2002; Ruetz et al., 2003). This evaluation provides a
therapeutic advantage for NTP, which causes G2/M arrest
in U266 cells.
We also showed that NTP induces apoptosis in MM
cells. Various other TCAs were all reported to have the
same effect on tumor cell lines (Frick and Rapanelli, 2013).
In particular, NTP induced caspase-dependent apoptosis
in bladder cancer cells by both mitochondria and death
receptor-mediated pathways (Yuan et al., 2015). Zhang
et al. studied amitriptyline triggered apoptosis in MM
xenograft models (Zhang et al., 2013).
In this work, we showed dose- and time-dependent
inhibitory effects of the antidepressant drug nortriptyline
on the U266 MM cell line. It was also demonstrated that in
vitro potency of NTP was greater than that of cisplatin, a
well-known cancer drug. Previous studies on NTP showed
minimal or no toxicity to normal blood cells and in vivo
antitumor effects. Our study provides the first in vitro
evidence of NTP-induced cell cycle arrest and apoptosis in
U266 cells. The molecular mechanism of both outcomes
should be elucidated and compared to those of other
antidepressants. Also, based on the reported results, NTP
warrants further investigation using in vivo MM models.
Antidepressants are commonly used in adjuvant therapy
for depression and pain relief. Therefore, antagonism of
the cis-NTP combination was another clinically significant
finding in this work. In future studies, additional dose
combinations can be tested to investigate the changes in
the type and strength of the combination effect.
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